Semler Scientific (NASDAQ:SMLR – Get Free Report) issued its quarterly earnings data on Tuesday. The company reported $3.41 EPS for the quarter, topping the consensus estimate of $0.20 by $3.21, Zacks reports. Semler Scientific had a return on equity of 20.31% and a net margin of 27.00%.
Semler Scientific Price Performance
Shares of SMLR opened at $50.72 on Wednesday. The firm has a market cap of $470.17 million, a P/E ratio of 24.74 and a beta of 1.17. The stock has a 50 day simple moving average of $57.63 and a two-hundred day simple moving average of $42.29. Semler Scientific has a 1 year low of $20.88 and a 1 year high of $81.56.
Analyst Upgrades and Downgrades
Separately, Lake Street Capital upped their target price on Semler Scientific from $40.00 to $71.00 and gave the stock a “buy” rating in a research note on Friday, January 24th.
About Semler Scientific
Semler Scientific, Inc provides technology solutions to enhance the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition.
Featured Stories
- Five stocks we like better than Semler Scientific
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- There’s Room to Chase These 3 Stocks Trading Near 52-Week Highs
- What is a Secondary Public Offering? What Investors Need to Know
- 3 Stocks With Robust Growth Outlooks Insiders Are Buying
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Buffett’s Billion-Dollar Bet: Will Constellation Brands Pay Off?
Receive News & Ratings for Semler Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Semler Scientific and related companies with MarketBeat.com's FREE daily email newsletter.
